Ipsos’ largest public survey in its history. 50,000 interviews, 50 markets (including Vietnam), 74% of the world's population and 90% of the world's Gross Domestic Product.
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
Committing to diversity, equity and inclusion within advertising goes beyond simply doing what is right for society; it is a strategic move that yields both immediate and long-term benefits for brands.
Ipsos has launched Ipsos PersonaBot. This AI-powered tool, powered by Ipsos Facto, allows organizations to engage in conversations with personas representing their target audience. Ipsos PersonaBot is available for both consumer and healthcare sectors.
